Nurse-led home-visitation programme for first-time mothers in reducing maltreatment and improving child health and development (BB:2-6): longer-term outcomes from a randomised cohort using data linkage.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 02 2022
Historique:
entrez: 11 2 2022
pubmed: 12 2 2022
medline: 23 3 2022
Statut: epublish

Résumé

Measure effectiveness of family nurse partnership (FNP) home-visiting programme in reducing maltreatment and improving maternal health and child health, developmental and educational outcomes; explore effect moderators, mediators; describe costs. Follow-up of BB:0-2 trial cohort (ISRCTN:23019866) up to age 7 years in England using record linkage. 1618 mothers aged 19 years or younger and their firstborn child(ren) recruited to BB:0-2 trial at less than 25 weeks gestation and not mandatorily withdrawn from trial or opted out. Intervention families were offered up to a maximum of 64 home visits by specially trained nurses from pregnancy until firstborn child was 2 years old, plus usually provided health and social care support. Comparator was usual care alone. Primary outcome: state-verified child-in-need status recorded at any time during follow-up. referral to social services, child protection registration (plan), child-in-need categorisation, looked-after status, recorded injuries and ingestions any time during follow-up, early childcare and educational attendance, school readiness and attainment at key stage 1 (KS1), healthcare costs. Match rates for 1547 eligible children (1517 singletons, 15 sets of twins) were 98.3% (NHS Digital) and 97.4% (National Pupil Database). There was no difference between study arms in the proportion of children being registered as in need (adjusted OR 0.98, 95% CI 0.74 to 1.31), or for any other measure of maltreatment. Children in the FNP arm were more likely to achieve a good level of development at reception age (school readiness) (adjusted OR 1.24, 95% CI 1.01 to 1.52). After adjusting for birth month, children in FNP arm were more likely to reach the expected standard in reading at KS1 (adjusted OR 1.26, 95% CI 1.02 to 1.57). We found no trial arm differences for resource use and costs. FNP did not improve maltreatment or maternal outcomes. There was evidence of small advantages in school readiness and attainment at KS1. ISRCTN23019866.

Identifiants

pubmed: 35144944
pii: bmjopen-2021-049960
doi: 10.1136/bmjopen-2021-049960
pmc: PMC8845181
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e049960

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K023233/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Dev Psychopathol. 2009 Spring;21(2):441-53
pubmed: 19338692
BMC Health Serv Res. 2017 Apr 17;17(1):274
pubmed: 28412944
JAMA. 1997 Aug 27;278(8):637-43
pubmed: 9272895
Pilot Feasibility Stud. 2018 Jun 28;4:98
pubmed: 29988307
Pediatrics. 1994 Jan;93(1):89-98
pubmed: 8265329
Int J Environ Res Public Health. 2017 Aug 28;14(9):
pubmed: 28846657
Health Soc Care Community. 2019 Sep;27(5):1344-1352
pubmed: 31157940
Pediatrics. 2004 Dec;114(6):1550-9
pubmed: 15574614
Pediatrics. 2013 Nov;132 Suppl 2:S100-9
pubmed: 24187111
BMC Pediatr. 2013 Aug 06;13:114
pubmed: 23919573
J Econ Perspect. 2013 Spring;27(2):109-132
pubmed: 25663745
Pediatrics. 2002 Sep;110(3):486-96
pubmed: 12205249
Int J Popul Data Sci. 2019 Nov 20;4(2):1134
pubmed: 34095541
Lancet. 2016 Jan 9;387(10014):146-55
pubmed: 26474809
Pediatrics. 1986 Jul;78(1):65-78
pubmed: 2425334
BMC Med Inform Decis Mak. 2009 Jan 16;9:3
pubmed: 19149883
JAMA. 1997 Aug 27;278(8):644-52
pubmed: 9272896
Lancet. 2016 Apr 16;387(10028):1615-6
pubmed: 27116069
Prev Sci. 2002 Sep;3(3):153-72
pubmed: 12387552
J Biomed Inform. 2014 Aug;50:196-204
pubmed: 24440148
Psychol Health Med. 2011 Dec;16(6):736-48
pubmed: 21678194
Pediatrics. 1995 Mar;95(3):365-72
pubmed: 7862474
BMC Public Health. 2018 Oct 10;18(1):1164
pubmed: 30305071
BMJ Open. 2017 Jul 13;7(7):e015728
pubmed: 28710218
Dev Psychol. 2007 Nov;43(6):1428-1446
pubmed: 18020822
Lancet. 2016 Jan 9;387(10014):105-7
pubmed: 26474806
Child Maltreat. 2006 Nov;11(4):301-12
pubmed: 17043315
PLoS One. 2015 Apr 01;10(4):e0120182
pubmed: 25830242
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
BMJ Open. 2018 May 5;8(5):e020152
pubmed: 29730623
Pediatr Surg Int. 2019 Jul;35(7):779-784
pubmed: 31076869
Lancet. 2016 Apr 16;387(10028):1616-7
pubmed: 27116070

Auteurs

Michael Robling (M)

Centre for Trials Research, Cardiff University, Cardiff, UK roblingmr@cardiff.ac.uk.
DECIPHer, School of Social Sciences, Cardiff University, Cardiff, UK.

Fiona V Lugg-Widger (FV)

Centre for Trials Research, Cardiff University, Cardiff, UK.

Rebecca Cannings-John (R)

Centre for Trials Research, Cardiff University, Cardiff, UK.

Lianna Angel (L)

Centre for Trials Research, Cardiff University, Cardiff, UK.

Sue Channon (S)

Centre for Trials Research, Cardiff University, Cardiff, UK.

Deborah Fitzsimmons (D)

Swansea Centre for Health Economics, Swansea University, Swansea, UK.

Kerenza Hood (K)

Centre for Trials Research, Cardiff University, Cardiff, UK.

Joyce Kenkre (J)

Faculty of Life Sciences and Education, University of South Wales, Pontypridd, UK.

Gwenllian Moody (G)

Centre for Trials Research, Cardiff University, Cardiff, UK.

Eleri Owen-Jones (E)

Centre for Trials Research, Cardiff University, Cardiff, UK.

Rhys D Pockett (RD)

Swansea Centre for Health Economics, Swansea University, Swansea, UK.

Julia Sanders (J)

School of Healthcare Sciences, Cardiff University, Cardiff, UK.

Jeremy Segrott (J)

Centre for Trials Research, Cardiff University, Cardiff, UK.
DECIPHer, School of Social Sciences, Cardiff University, Cardiff, UK.

Thomas Slater (T)

School of Social Sciences, Cardiff University, Cardiff, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH